bpc-157 clinical trial registered (RUO) – Tide Labs BPC-157 - DrWell
Description
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
No long-term human studies confirm the extent or permanence of hormonal effects
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
10.1002/ijc.29095 [DOI] [PubMed] [Google Scholar] 72.Horenstein AL, Chillemi A, Quarona V, Zito A, Roato I, Morandi F, et al
Of those 36, 35 were preclinical studies conducted in animals
